Dr Carena Lee Chai, DO | |
1600 Providence Dr, Waco, TX 76707-2261 | |
(254) 313-4200 | |
(254) 313-4531 |
Full Name | Dr Carena Lee Chai |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 21 Years |
Location | 1600 Providence Dr, Waco, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063579704 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 1881 (Tennessee) | Secondary |
207Q00000X | Family Medicine | M2584 (Texas) | Primary |
207Q00000X | Family Medicine | TP024 (Kentucky) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Texas Home Health Group Of Waco Llc | Waco, TX | Home health agency |
Baylor Scott & White Medical Center Hillcrest | Waco, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Heart Of Texas Community Health Center, Inc. | 1153370242 | 95 |
News Archive
eLINCx, founded earlier this year to provide quality healthcare services to central Ohio communities, and GE Healthcare announced today that eLINCx will implement GE Healthcare's eHealth Information Exchange across Wooster Community Hospital, Dunlap Community Hospital and more than a dozen physician practices.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 1 days ago
Entity Name | Mclennan County Medical Education And Research Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689651440 PECOS PAC ID: 0042205155 Enrollment ID: O20040419000208 |
News Archive
eLINCx, founded earlier this year to provide quality healthcare services to central Ohio communities, and GE Healthcare announced today that eLINCx will implement GE Healthcare's eHealth Information Exchange across Wooster Community Hospital, Dunlap Community Hospital and more than a dozen physician practices.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 1 days ago
Entity Name | Heart Of Texas Community Health Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568191492 PECOS PAC ID: 1153370242 Enrollment ID: O20050114000813 |
News Archive
eLINCx, founded earlier this year to provide quality healthcare services to central Ohio communities, and GE Healthcare announced today that eLINCx will implement GE Healthcare's eHealth Information Exchange across Wooster Community Hospital, Dunlap Community Hospital and more than a dozen physician practices.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Carena Lee Chai, DO 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 | Dr Carena Lee Chai, DO 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 |
News Archive
eLINCx, founded earlier this year to provide quality healthcare services to central Ohio communities, and GE Healthcare announced today that eLINCx will implement GE Healthcare's eHealth Information Exchange across Wooster Community Hospital, Dunlap Community Hospital and more than a dozen physician practices.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.
› Verified 1 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Dr. Aman A Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Dr. Rita L Haws, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 Fax: 254-313-4549 |